Effectiveness of cyclosporine and mycophenolate mofetil in a child with refractory evans syndrome
Evans Syndrome is a rare autoimmune disease consisting of hemolytic anemia, thrombocytopenia and/or neutropenia. It may be associated with other autoimmune or lymphoproliferative diseases. Its course can be extremely serious and, rarely, even life-threatening; thus it represents a excellent treatment challenge for the pediatric hematologist. First line treatment consists of steroids and/or immunoglobulin; further therapy with rituximab, vincristine, cyclophosphamide and other immunosuppressive drugs can be considered in unresponsive patients. We describe a baby with refractory Evans Syndrome that was cured by prolonged administration of mycophenolate mofetil and remained disease-free for 4 years after the discontinuation of treatment.
Evans’ syndrome, Cyclosporine, Mycophenolate mofetil, Treatment, Outcome
Full Text:PDF HTML
Submitted: 2011-03-24 23:02:10
Published: 2011-05-16 09:07:57
Search for citations in Google Scholar
Related articles: Google Scholar